Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF
Study Details
Study Description
Brief Summary
The COVID-19 pandemic of SARS CoV2 (Severe Acute Respiratory Syndrome, COVID-19) infection, which is currently evolving in France, raises many questions about the clinical and biological profile of infected hospitalized patients. If certain biological factors like troponin, BNP (Brain Natriuretic Peptid), or clinical factors like cardiovascular history or oncological history are associated with a worse prognosis, available data comes from studies in Asia for the majority, or including a limited number of patients. Patient stratification remains a major issue for patient sorting and early referral of patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
This study is observational, multicenter and retrospective, and is conducted in hospitals in France.
Clinical data relating to history, comorbidities, risk factors, previous treatments, treatments during the hospitalization and treatments at the discharge from hospital, clinical parameters, biological and ultrasound cardiological data, procedures and events during hospitalization will be recorded, in order to identify the early predictors of clinical worsening in patients hospitalized for COVID-19 in cardiology or conventional medicine department.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patients with COVID-19 Patients hospitalized in conventional sector with diagnosis of COVID-19 (positive PCR (Polymerase Chain Reaction) or diagnosis presumed by the clinical and radiographic picture) |
Outcome Measures
Primary Outcome Measures
- Death rate [Through study completion, an average of 4 weeks]
Analysis of all-cause death in relation with clinical patient profile
- Transfer to intensive care unit [Through study completion, an average of 4 weeks]
Correlation between clinical patient profile and transfer need to intensive care unit
- Ventilation analysis [Through study completion, an average of 4 weeks]
Type of ventilation procedures needed during the hospitalization (Orotracheal intubation for mechanical ventilation or Non-invasive ventilation or 29/5000 high flow oxygen therapy - Optiflow) in relation with clinical patient profile
Secondary Outcome Measures
- Construction of a predictive score for COVID-19 severe form [Through study completion, an average of 4 weeks]
Description of clinical and biological patient profile leading to a worse prognosis
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients hospitalized in cardiology unit or medicine conventional sector with diagnosis of COVID-19 (positive PCR (Polymerase Chain Reaction) or diagnosis presumed by the clinical and radiographic picture)
Exclusion Criteria:
-
Minors
-
Pregnant women
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | CHU d'Amiens | Amiens | France | 80054 | |
2 | CHU Annecy | Annecy | France | 74374 | |
3 | CHU de Bordeaux | Bordeaux | France | 33404 | |
4 | CHU de Caen | Caen | France | 14033 | |
5 | Cotentin hospital | Cherbourg | France | 50100 | |
6 | CHU Dijon | Dijon | France | 21079 | |
7 | Elbeuf Louviers Val de Reuil | Elbeuf | France | 76500 | |
8 | CHU de Fréjus / Saint-Raphael | Fréjus | France | 83608 | |
9 | Lille Catholic Institute Hospital Group, Lille | Lille | France | 59000 | |
10 | CHU de Lyon | Lyon | France | 69229 | |
11 | APHM | Marseille | France | 13000 | |
12 | Jacques Cartier Private Hospital, Massy | Massy | France | 91300 | |
13 | CHR d'Orléans | Orléans | France | ||
14 | Bichat (APHP) | Paris | France | 75000 | |
15 | Georges Pompidou European Hospital (AP-HP) | Paris | France | 75000 | |
16 | Institut Mutualiste Montsouris, Paris | Paris | France | 75000 | |
17 | CHU de Reims | Reims | France | 51092 | |
18 | CHU de Rouen | Rouen | France | 76000 | |
19 | CHU Saint Etienne | Saint-Étienne | France | 42055 | |
20 | CHU de Strasbourg | Strasbourg | France | 67000 | |
21 | CHU de Toulouse | Toulouse | France | 31000 | |
22 | Saint Gatien hospital | Tours | France | 3540 | |
23 | CHU de Nancy | Vandœuvre-lès-Nancy | France | 54500 |
Sponsors and Collaborators
- French Cardiology Society
- Institut National de la Santé Et de la Recherche Médicale, France
Investigators
- Study Director: Guillaume BONNET, MD, Hopital Européen Georges Pompidou
- Principal Investigator: Orianne WEIZMAN, MD, CHU de Nancy
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2020-02